On August 29, 2013, ITC Nexus Holding Company announced it had acquired Accumetrics, a global leader in assessing patient response to all major antiplatelet therapies. The integration of the ITC and Accumetrics businesses is currently underway and the leadership teams are working closely to insure a seamless transition for our customers. The Accriva mission is to create a leading hospital-based Point-of-Care cardiovascular diagnostics business.